Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.

[1]  C. Bartram,et al.  Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women. , 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[2]  C. Castelo-Branco,et al.  Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate. , 1996, Journal of reproductive medicine.

[3]  H. Bennink,et al.  Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study. , 1996, Bone.

[4]  S. Cummings,et al.  Estrogen Replacement Therapy and Fractures in Older Women , 1995, Annals of Internal Medicine.

[5]  H. Burger,et al.  Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. , 1995, Maturitas.

[6]  N. Watts,et al.  Comparison of Oral Estrogens and Estrogens Plus Androgen on Bone Mineral Density, Menopausal Symptoms, and Lipid‐Lipoprotein Profiles in Surgical Menopause , 1995, Obstetrics and gynecology.

[7]  C. Castelo-Branco,et al.  Postmenopausal hormone replacement therapy with low-dose medroxyprogesterone acetate. Endometrium, plasma lipids, lipoproteins and apolipoproteins. , 1995, Journal of reproductive medicine.

[8]  S. Yen,et al.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. , 1994, The Journal of clinical endocrinology and metabolism.

[9]  A. Peretz,et al.  Decrease of bone mineral density during estrogen substitution therapy. , 1993, Maturitas.

[10]  C. Castelo-Branco,et al.  Effects of oophorectomy and hormone replacement therapy on plasma lipids. , 1993, Maturitas.

[11]  C. Castelo-Branco,et al.  Bone mineral density in surgically postmenopausal women receiving hormonal replacement therapy as assessed by dual photon absorptiometry. , 1993, Maturitas.

[12]  C. Castelo-Branco,et al.  The effect of hormone replacement therapy on postmenopausal bone loss. , 1992, European journal of obstetrics, gynecology, and reproductive biology.

[13]  A. Cano,et al.  Effect of continuous oestradiol-medroxyprogesterone administration on plasma lipids and lipoproteins. , 1991, Maturitas.

[14]  K. Friedl,et al.  Serum lipids and lipoproteins in continuous or cyclic medroxyprogesterone acetate treatment in postmenopausal women treated with conjugated estrogens. , 1990, Fertility and sterility.

[15]  W. Hazzard,et al.  Estrogen replacement and cardiovascular disease: serum lipids and blood pressure effects. , 1989 .

[16]  D. Phillips,et al.  Sex Steroids and Bone Density in Premenopausal and Perimenopausal Women , 1989 .

[17]  C. Christiansen,et al.  Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women. , 1989, Maturitas.

[18]  J. Wergedal,et al.  Androgens directly stimulate proliferation of bone cells in vitro. , 1989, Endocrinology.

[19]  C. Fletcher,et al.  Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/ progestogen therapy , 1989, British journal of obstetrics and gynaecology.

[20]  A. Vermeulen,et al.  Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late post-menopause. , 1989, Maturitas.

[21]  B. Riggs,et al.  Identification of androgen receptors in normal human osteoblast-like cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Savvas,et al.  Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women. , 1988, BMJ.

[23]  A. Luciano,et al.  Clinical and Metabolic Responses of Menopausal Women to Sequential Versus Continuous Estrogen and Progestin Replacement Therapy , 1988, Obstetrics and gynecology.

[24]  N. M. Morris,et al.  Marital sex frequency and midcycle female testosterone , 1987, Archives of sexual behavior.

[25]  C C Johnston,et al.  Steroid and gonadotropin levels in women during the peri-menopausal years. , 1986, Maturitas.

[26]  B. Sherwin,et al.  Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. , 1985, Psychosomatic medicine.

[27]  C. Fletcher,et al.  The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women. , 1984, Acta endocrinologica.

[28]  H. Brewer,et al.  The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. , 1983, The Journal of clinical endocrinology and metabolism.

[29]  M. Dow,et al.  Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study , 1983, British journal of obstetrics and gynaecology.

[30]  M. Dougherty,et al.  Lipids and lipoproteins in women after oophorectomy and the response to oestrogen therapy , 1983, British journal of obstetrics and gynaecology.

[31]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[32]  C. Christiansen,et al.  Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females , 1971, European journal of clinical investigation.

[33]  J. Simon,et al.  P-22.: Cognitive Function, Mood and Quality of Life , 1997 .

[34]  D. Butler,et al.  Clinical experience with tibolone (Livial) over 8 years. , 1995, Maturitas.